JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription

被引:34
|
作者
Han, YL
Watling, D
Rogers, NC
Stark, GR
机构
[1] CLEVELAND CLIN FDN, RES INST, DEPT MOL BIOL, CLEVELAND, OH 44195 USA
[2] IMPERIAL CANC RES FUND, LONDON WC2A 3PX, ENGLAND
关键词
D O I
10.1210/me.11.8.1180
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several different Janus kinases (JAKs) and signal transducers and activation of transcription (STATs) have been implicated in mediating the biological responses induced by PRL, based on their ligand-dependent tyrosine phosphorylation and activation. However, these criteria alone do not prove that a particular JAK or STAT is essential for signal transduction. We have used mutant cell lines defective in JAK1, JAK2, or STAT1 to examine their roles in PRL-dependent signaling. JAK2 is absolutely required for PRL-dependent phosphorylation of the receptor, activation of STATs, and induction of beta-lactoglobulin. Wild type, but not kinase-negative JAK2, restores all responses to PRL in JAK2-defective cells, suggesting that JAK2 function, not merely the protein, is required. In contrast, JAK1, which is phosphorylated in response to PRL, is not required for any of these functions. Although STAT1 homodimers do form in response to PRL, no defect in PRL-dependent signaling is apparent when STAT1 is missing, suggesting that STAT5, which is strongly activated in response to PRL, is primarily responsible for driving the expression of PRL-responsive genes.
引用
收藏
页码:1180 / 1188
页数:9
相关论文
共 50 条
  • [1] JAK2/STAT5 Pathway Mediates Prolactin-Induced Apoptosis of Lactotropes
    de Dios, Nataly
    Orrillo, Santiago
    Irizarri, Martin
    Susana Theas, Maria
    Boutillon, Florence
    Candolfi, Marianela
    Seilicovich, Adriana
    Goffin, Vincent
    Pisera, Daniel
    Ferraris, Jimena
    [J]. NEUROENDOCRINOLOGY, 2019, 108 (02) : 84 - 97
  • [2] An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans
    Brelje, TC
    Svensson, AM
    Stout, LE
    Bhagroo, NV
    Sorenson, RL
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2002, 50 (03) : 365 - 383
  • [3] In vitro interaction between STAT5 and JAK2;: dependence upon phosphorylation status of STAT5 and JAK2
    Flores-Morales, A
    Pircher, TJ
    Silvennoinen, O
    Gustafsson, JÅ
    Sanchez-Gomez, M
    Norstedt, G
    Haldosén, LA
    Wood, TJJ
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 138 (1-2) : 1 - 10
  • [4] Interleukin 3 activates not only JAK2 and STAT5, but also Tyk2, STAT1, and STAT3
    Nagata, Y
    Todokoro, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 221 (03) : 785 - 789
  • [5] Regulation of STAT1 nuclear export by Jak1
    Mowen, K
    David, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (19) : 7273 - 7281
  • [6] Activated STAT1 and STAT5 transcription factors in extramedullary hematopoietic tissue in a polycythemia vera patient carrying the JAK2 V617F mutation
    Meyer, Thomas
    Ruppert, Volker
    Goerg, Christian
    Neubauer, Andreas
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (01) : 117 - 120
  • [7] STAT1 activation in association with JAK2 exon 12 mutations
    Godfrey, Anna L.
    Chen, Edwin
    Massie, Charles E.
    Silber, Yvonne
    Pagano, Francesca
    Bellosillo, Beatriz
    Guglielmelli, Paola
    Harrison, Claire N.
    Reilly, John T.
    Stegelmann, Frank
    Bijou, Fontanet
    Lippert, Eric
    Boiron, Jean-Michel
    Doehner, Konstanze
    Vannucchi, Alessandro M.
    Besses, Carlos
    Green, Anthony R.
    [J]. HAEMATOLOGICA, 2016, 101 (01) : E15 - E19
  • [8] Activated STAT1 and STAT5 transcription factors in extramedullary hematopoietic tissue in a polycythemia vera patient carrying the JAK2 V617F mutation
    Thomas Meyer
    Volker Ruppert
    Christian Görg
    Andreas Neubauer
    [J]. International Journal of Hematology, 2010, 91 : 117 - 120
  • [9] Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2
    Grebien, Florian
    Kerenyi, Marc A.
    Kovacic, Boris
    Kolbe, Thomas
    Becker, Verena
    Dolznig, Helmut
    Pfeffer, Klaus
    Klingmueller, Ursula
    Mueller, Mathias
    Beug, Hartmut
    Muellner, Ernst W.
    Moriggl, Richard
    [J]. BLOOD, 2008, 111 (09) : 4511 - 4522
  • [10] DIFFERENTIAL TYROSINE PHOSPHORYLATION OF JAK1, JAK2, AND STAT1 BY GROWTH-HORMONE AND INTERFERON-GAMMA IN IM-9 CELLS
    SILVA, CM
    LU, HW
    WEBER, MJ
    THORNER, MO
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (44) : 27532 - 27539